Propanc Biopharma issues $53,750 convertible note to Red Road with 35% discount conversion

Propanc Biopharma, Inc.

Principal $53,750, net proceeds $50,000 after $3,750 fees; maturity Oct 6, 2023; 8% interest.
Conversion price set at 65% of average lowest 3 trading prices in prior 10 days (35% discount).
Prepayment premiums range from 110% to 129% of face amount; conversion begins 180 days after issuance.
Default includes failure to deliver shares, OTC delisting, or financial restatement; default amount 150%.
Note sold in private placement under Section 4(a)(2) and Regulation D; proceeds for working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.